Celltrion holdings Nasdaq

South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has applied for CT-P39, a biosimilar of the treatment of asth...

Viva Republica Inc., the operator of South Korea’s fintech platform Toss, has revived plans to go public after pushing back its stock market d...

South Korean Kakao Pay Corp.'s takeover deal of US-based Siebert Financial Corp. has failed amid the growing legal risks surrounding top executives ...

Cho Yang-rai, honorary chairman of Hankook & Company Co., has vowed to fight MBK Partners Ltd.’s bid to take over the holding company of S...

South Korea's Celltrion Healthcare Co. announced on Tuesday that its anti-cancer biosimilar Vegzelma (active ingredient: bevacizumab) was listed as ...

Celltrion Healthcare Co. announced on Thursday that its biosimilar anticancer drug Herzuma (active ingredient trastuzumab) for breast and gastr...

South Korea’s biopharmaceutical company Celltrion Inc. announced on Wednesday that it signed a joint research agreement with domestic startup ...

Celltrion Healthcare Co. announced on Thursday that its autoimmune disease treatment Zymfentra (the US product name for Remsima SC) is set to be lau...

South Korea's JW Holdings corporation announced on Tuesday that it started to export the multi-nutritional liquid Winuf Central 736·1085ml to...

South Korean biopharmaceutical company Celltrion Inc. announced on Friday that it applied for approval from the European Medicines Agency (EMA) for ...

Corporate governance and management transparency have long been the big issues influencing the so-called Korea Discount, alongside labor strife and ...

Samsung Electronics Co., the world’s largest memory chipmaker, has divested a 0.3% stake in Dutch chip equipment manufacturer ASML Holdings N....

South Korea's P&O Chemical, a joint venture of POSCO Future M Co. and OCI Holdings Co. completed the pitch plant in Tancheon Industrial Complex,...

South Korea's Celltrion Healthcare Co. announced on Friday its autoimmune disease treatment Remsima (ingredient: infliximab) has won a bid for the B...

South Korea's POSCO Holdings Inc. announced on Wednesday it signed a memorandum of understanding (MOU) with Invest Alberta Corporation (IAC) in Seou...

South Korean pharmaceutical giant Celltrion Inc. logged record quarterly earnings on the strong performance of its key biosimilar products while exp...

Brompton Bicycle will pursue a greener world with sustainable clothing that is stylish but durable alongside its Korean partner The Nature Holdings ...

The South Korean government is planning to sell off a 29.3% stake in Tokyo-listed game giant Nexon Co.’s holding firm NXC Corp. via a public b...

DearU Co., a K-pop fandom platform in South Korea, announced the launch of the Japanese version of "bubble" on Tuesday. DearU bubble is a private me...

Global private equity giant KKR & Co. Inc. is expected to take over Taeyoung Industry Corp., a cash cow of South Korea’s medium-sized busi...

South Korea’s biosimilar drugmaker Celltrion group on Monday moved one step closer to the planned combination of its three major affiliates wi...

South Korea's Celltrion Inc. announced on Monday it received a new drug approval for an autoimmune disease treatment Remsima SC (active ingredient i...

South Korean memory chip giant SK Hynix Inc. is rumored to be frowning on the integration of Japan’s Kioxia Holdings Corp. with US-based Weste...

South Korea's Celltrion Healthcare Co. announced on Wednesday its autoimmune disease treatment Remsima (ingredient: infliximab) has won a bid for ho...

South Korea's Celltrion Healthcare Co. has inked a deal with the US specialty pharmacy chain CarePartners Pharmacy to supply its autoimmune disease ...

South Korea's Kia Corp. held a global distributors convention for the first time in five years, sharing medium to long-term business strategies, inc...

South Korea's Hyundai Capital announced on Wednesday it will acquire the Indonesian finance firm PT Paramitra Multifinance to enter the local market...

South Korean drug giant Celltrion Group has received a positive recommendation from Institutional Shareholder Services (ISS), a global leading proxy...

South Korean food company Daesang Corp. on Friday said it is holding through Oct. 15 the country’s first kimchi pop-up store “Kimchi Bla...

South Korean natural killer (NK) cell drugmaker NKMax Co. on Wednesday said its US subsidiary NKGen Biotech on Monday was listed on the Nasdaq Globa...